Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer
CONCLUSIONS: The performance of the Precision Lasso model in selecting related genes could be considered more acceptable rather than other models.PMID:37357234 | DOI:10.1186/s43046-023-00172-5 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 25, 2023 Category: Cancer & Oncology Authors: Rashed Pourhamidi Azam Moslemi Source Type: research
Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer
CONCLUSIONS: The performance of the Precision Lasso model in selecting related genes could be considered more acceptable rather than other models.PMID:37357234 | DOI:10.1186/s43046-023-00172-5 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 25, 2023 Category: Cancer & Oncology Authors: Rashed Pourhamidi Azam Moslemi Source Type: research
Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer
CONCLUSIONS: The performance of the Precision Lasso model in selecting related genes could be considered more acceptable rather than other models.PMID:37357234 | DOI:10.1186/s43046-023-00172-5 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 25, 2023 Category: Cancer & Oncology Authors: Rashed Pourhamidi Azam Moslemi Source Type: research
Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer
CONCLUSIONS: The performance of the Precision Lasso model in selecting related genes could be considered more acceptable rather than other models.PMID:37357234 | DOI:10.1186/s43046-023-00172-5 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 25, 2023 Category: Cancer & Oncology Authors: Rashed Pourhamidi Azam Moslemi Source Type: research
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research
Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia
CONCLUSION: ETP-ALL patients tend to have increased mortalities. There was no significant impact of TCR aberrations on the survival rates of the patients.PMID:37303010 | DOI:10.1186/s43046-023-00176-1 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 11, 2023 Category: Cancer & Oncology Authors: Mona S El Ashry Enas Radwan Mona S Abdellateif Omar Arafah Naglaa M Hassan Source Type: research
Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia
CONCLUSION: ETP-ALL patients tend to have increased mortalities. There was no significant impact of TCR aberrations on the survival rates of the patients.PMID:37303010 | DOI:10.1186/s43046-023-00176-1 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 11, 2023 Category: Cancer & Oncology Authors: Mona S El Ashry Enas Radwan Mona S Abdellateif Omar Arafah Naglaa M Hassan Source Type: research
Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia
CONCLUSION: ETP-ALL patients tend to have increased mortalities. There was no significant impact of TCR aberrations on the survival rates of the patients.PMID:37303010 | DOI:10.1186/s43046-023-00176-1 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 11, 2023 Category: Cancer & Oncology Authors: Mona S El Ashry Enas Radwan Mona S Abdellateif Omar Arafah Naglaa M Hassan Source Type: research
Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia
CONCLUSION: ETP-ALL patients tend to have increased mortalities. There was no significant impact of TCR aberrations on the survival rates of the patients.PMID:37303010 | DOI:10.1186/s43046-023-00176-1 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 11, 2023 Category: Cancer & Oncology Authors: Mona S El Ashry Enas Radwan Mona S Abdellateif Omar Arafah Naglaa M Hassan Source Type: research
Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia
CONCLUSION: ETP-ALL patients tend to have increased mortalities. There was no significant impact of TCR aberrations on the survival rates of the patients.PMID:37303010 | DOI:10.1186/s43046-023-00176-1 (Source: J Egypt Natl Canc In...)
Source: J Egypt Natl Canc In... - June 11, 2023 Category: Cancer & Oncology Authors: Mona S El Ashry Enas Radwan Mona S Abdellateif Omar Arafah Naglaa M Hassan Source Type: research
